InSightec Announces HCSC Positive Coverage Decision for its MRgFUS Procedure for Pain Palliation of Bone Cancer Metastases

News provided by

Oct 06, 2014, 08:00 ET

HAIFA, Israel, Oct. 6, 2014 /PRNewswire/ -- InSightec today announced that Health Care Service Corporation (HCSC) has published updates to their Magnetic Resonance Imaging-guided Focused Ultrasound (MRgFUS) coverage policy and is now providing benefits for InSightec's ExAblate® procedure as a treatment option that is FDA-cleared for patients suffering from pain associated with bone metastases.

HCSC is the second largest Blue Cross and Blue Shield commercial insurer in the United States with over 14 million covered members, and represents one of the top insurers in TX, OK, IL, NM and MT.

"Decisions from leading insurers to cover InSightec's treatment are a welcome recognition of the demonstrated clinical benefits for ExAblate's completely noninvasive treatment for patients suffering from pain associated with bone metastases," said Kobi Vortman, PhD, CEO of InSightec. "Since receiving FDA approval, patients have been provided access from insurers on a case-by-case basis. By formalizing a favorable coverage policy, HCSC has made access to MRgFUS a viable option for many more patients and physicians," he emphasized.

"We are very happy that our efforts have yielded a favorable decision which will enable patients to benefit from a noninvasive treatment that quickly reduces pain, allows return to normal activities within days and is available in leading medical centers across the U.S.," said Dee Kolanek, Global Reimbursement Director of InSightec. "We are continuously conducting independent post-market studies in efforts to build support for additional coverage by insurers," she added.

Notes to Editor:

About InSightec

INSIGHTEC is a world leader in MR-guided Focused Ultrasound (MRgFUS). The company, founded in 1999, has developed a completely non-invasive therapy platform that transforms medicine in an expanding number of neurosurgery, oncology and gynecology indications. MRgFUS is already adopted and used by world recognized physicians in more than 120 leading medical facilities around the world, who see the tremendous clinical and economical value of the InSightec therapy platform.

The company has received numerous awards for innovation from well-respected organizations including the Wall Street Journal, the European Union and TIME Magazine. The company is privately held by GE Healthcare, Elbit Imaging, York Capital Management, GEOC Hengtong Investment Limited Partnership and MediTech Advisors. For more information please visit: www.insightec.com

About Health Care Service Corporation

Health Care Service Corporation (HCSC) is the largest customer-owned health insurance company in the United States. HCSC offers a wide variety of health and life insurance products and related services, through its operating divisions and subsidiaries; including Blue Cross and Blue Shield of Illinois, Blue Cross and Blue Shield of Montana, Blue Cross and Blue Shield of New Mexico, Blue Cross and Blue Shield of Oklahoma, Blue Cross and Blue Shield of Texas, and Dearborn National. The company employs more than 21,000 people and serves more than 14.5 million members.

Media Contact

Xen Mendelsohn Aderka
VP of Marketing
InSightec
[email protected]
+972-4-8131309

SOURCE InSightec